MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale of
units, net of...
$490,000,000
Proceeds from sale of
private placement units
$12,000,000
Net cash provided by
financing activities
$501,001,419
Canceled cashflow
$998,581
Net change in cash
-$16,812
Canceled cashflow
$501,001,419
Net income (loss)
$4,187,050
Provision for credit
losses
$812,113
Accounts payable
$99,359
Accrued expenses
$88,343
Payment of operating
costs through...
$77,799
Prepaid expenses
-$16,766
Repayment of promissory
note - related party
$533,781
Payment of offering
costs
$464,800
Net cash used in
investing activities
-$500,000,000
Net cash used in
operating activities
-$1,018,231
Canceled cashflow
$5,281,430
Investment of cash into
trust account
$500,000,000
Interest earned on cash
and investments...
$4,933,800
Due from sponsor
$812,113
Gain on
extinguishment of...
$553,748
Back
Back
Cash Flow
source: myfinsight.com
Drugs Made In America Acquisition II Corp. (DMIIR)
Drugs Made In America Acquisition II Corp. (DMIIR)